• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    LeMaitre Vascular, Inc. - Common Stock (NQ:LMAT)

    112.30 -2.52 (-2.19%)
    Streaming Delayed Price Updated: 1:21 PM EDT, Apr 16, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about LeMaitre Vascular, Inc. - Common Stock

    < Previous 1 2 3 4 5 6 Next >
    News headline image
    Q1 Earnings Highs And Lows: LeMaitre (NASDAQ:LMAT) Vs The Rest Of The Surgical Equipment & Consumables - Specialty Stocks
    Let’s dig into the relative performance of LeMaitre (NASDAQ:LMAT) and its peers as we unravel the now-completed Q1 surgical equipment & consumables - specialty earnings season. 
    Via StockStory
    Topics Artificial Intelligence Economy
    News headline image
    Why LeMaitre (LMAT) Shares Are Sliding Today
    Shares of medical device company LeMaitre Vascular (NASDAQ:LMAT) fell 12.2% in the afternoon session after the company reported weak first quarter 2025 results with a significant miss on full-year EPS... 
    Via StockStory
    Topics Artificial Intelligence
    News headline image
    LeMaitre’s (NASDAQ:LMAT) Q1: Beats On Revenue, Guides for Strong Full-Year Sales
    Medical device company LeMaitre Vascular (NASDAQ:LMAT) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 12% year on year to $59.87 million. Guidance for next... 
    Via StockStory
    News headline image
    Earnings Scheduled For May 1, 2025 ↗
     
    Via Benzinga
    News headline image
    Earnings Scheduled For February 27, 2025 ↗
     
    Via Benzinga
    News headline image
    Novocure Stock Earns 96 RS Rating ↗
    On Tuesday, Novocure stock got a positive adjustment to its Relative Strength (RS) Rating to 96, up from 73. 
    Via Investor's Business Daily
    News headline image
    In-Depth Examination Of 4 Analyst Recommendations For LeMaitre Vascular ↗
     
    Via Benzinga
    News headline image
    A Look at LeMaitre Vascular's Upcoming Earnings Report ↗
     
    Via Benzinga
    News headline image
    Earnings To Watch: LeMaitre (LMAT) Reports Q1 Results Tomorrow
    Medical device company LeMaitre Vascular (NASDAQ:LMAT) will be reporting results tomorrow after the bell. Here’s what you need to know. 
    Via StockStory
    Topics Artificial Intelligence World Trade
    News headline image
    1 Profitable Stock with Impressive Fundamentals and 2 to Steer Clear Of
    While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my... 
    Via StockStory
    News headline image
    Q4 Earnings Highlights: LeMaitre (NASDAQ:LMAT) Vs The Rest Of The Surgical Equipment & Consumables - Specialty Stocks
    Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at LeMaitre (NASDAQ:LMAT) and the best and... 
    Via StockStory
    Topics Artificial Intelligence Economy
    News headline image
    Analyst Scoreboard: 4 Ratings For LeMaitre Vascular ↗
     
    Via Benzinga
    News headline image
    Navigating 4 Analyst Ratings For LeMaitre Vascular ↗
     
    Via Benzinga
    News headline image
    3 Healthcare Stocks Facing Headwinds
    Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But speed bumps such as inventory destockings have persisted in the wake of COVID-19,... 
    Via StockStory
    Topics Stocks
    News headline image
    Spotting Winners: Teleflex (NYSE:TFX) And Surgical Equipment & Consumables - Specialty Stocks In Q4
    The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how surgical equipment & consumables - specialty stocks fared in... 
    Via StockStory
    Topics Artificial Intelligence Economy
    News headline image
    Why LEMAITRE VASCULAR INC (NASDAQ:LMAT) qualifies as a quality stock. ↗
    A fundamental analysis of (NASDAQ:LMAT): Why Quality Investors May Find LEMAITRE VASCULAR INC (NASDAQ:LMAT) Attractive. 
    Via Chartmill
    News headline image
    2 Reasons to Avoid LMAT and 1 Stock to Buy Instead
    Over the past six months, LeMaitre’s shares (currently trading at $83.18) have posted a disappointing 10.5% loss while the S&P 500 was down 4.1%. This may have investors wondering how to approach the... 
    Via StockStory
    Topics Stocks Supply Chain
    News headline image
    Winners And Losers Of Q4: Integra LifeSciences (NASDAQ:IART) Vs The Rest Of The Surgical Equipment & Consumables - Specialty Stocks
    Looking back on surgical equipment & consumables - specialty stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Integra LifeSciences (NASDAQ:IART) and its peers. 
    Via StockStory
    Topics Artificial Intelligence Economy
    News headline image
    Q4 Earnings Review: Surgical Equipment & Consumables - Specialty Stocks Led by Intuitive Surgical (NASDAQ:ISRG)
    As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the surgical equipment & consumables - specialty industry, including Intuitive... 
    Via StockStory
    Topics Artificial Intelligence Economy
    News headline image
    LeMaitre (NASDAQ:LMAT) Misses Q4 Sales Targets, Stock Drops 11%
    Medical device company LeMaitre Vascular (NASDAQ:LMAT) missed Wall Street’s revenue expectations in Q4 CY2024, but sales rose 14% year on year to $55.72 million. Next quarter’s revenue guidance of... 
    Via StockStory
    News headline image
    What To Expect From LeMaitre’s (LMAT) Q4 Earnings
    Medical device company LeMaitre Vascular (NASDAQ:LMAT) will be announcing earnings results tomorrow after the bell. Here’s what to expect. 
    Via StockStory
    News headline image
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
     
    Via Benzinga
    News headline image
    Inari Medical Stock Gets RS Rating Upgrade ↗
    On Wednesday, Inari Medical stock received an upgrade to its Relative Strength (RS) Rating, from 65 to 72. 
    Via Investor's Business Daily
    News headline image
    ResMed Is 80 And 80: Hits 80-Plus Relative Strength Rating After Rising 80% In A Year ↗
    ResMed also boasts a superb 96 EPS Rating out of 99, putting it in the top 4% of all companies for recent and long-term profit growth. 
    Via Investor's Business Daily
    News headline image
    Apple To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Friday ↗
     
    Via Benzinga
    News headline image
    This Synopsys Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday ↗
     
    Via Benzinga
    News headline image
    LMAT Stock Earnings: LeMaitre Vascular Beats EPS, Beats Revenue for Q2 2024 ↗
    LMAT stock results show that LeMaitre Vascular beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
    Via InvestorPlace
    News headline image
    Staar Surgical Stock Earns RS Rating Upgrade ↗
    On Thursday, lens maker Staar Surgical stock had its Relative Strength (RS) Rating upgraded to 87 from 77. 
    Via Investor's Business Daily
    News headline image
    Stryker Stock Sees RS Rating Treks Higher To 71 ↗
    Stryker stock saw a positive improvement to its Relative Strength (RS) Rating on Wednesday, with an increase from 63 to 71. 
    Via Investor's Business Daily
    News headline image
    Sell In May And Go Away? – April Dividend Income Report ↗
    The “Sell in May and Go Away” adage is wrong for most investors. 
    Via Talk Markets
    < Previous 1 2 3 4 5 6 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.